NADPH oxidase 2 as a potential therapeutic target for protection against cognitive deficits following systemic inflammation in mice

Wan Yu Huang, Ko Hung Liu, Shankung Lin, Ting Yu Chen, Chien Yu Tseng, Hsuan Ying Chen, Hung Ming Wu, Kuei Sen Hsu

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)


Background: Research indicates that sepsis increases the risk of developing cognitive impairment. After systemic inflammation, a corresponding activation of microglia is rapidly induced in the brain, and multiple neurotoxic factors, including inflammatory mediators (e.g., cytokines) and reactive oxygen species (e.g., superoxide), are also released that contribute to neuronal injury. NADPH oxidase (NOX) enzymes play a vital role in microglial activation through the generation of superoxide anions. We hypothesized that NOX isoforms, particularly NOX2, could exhibit remarkable abilities in developing cognitive deficits induced by systemic inflammation. Methods: Mice with deficits of NOX2 organizer p47phox (p47phox −/−) and wild-type (WT) mice treated with the NOX inhibitor diphenyleneiodonium (DPI) were used in this study. Intraperitoneal lipopolysaccharide (LPS) injection was used to induce systemic inflammation. Spatial learning and memory were compared among treatment groups using the radial arm maze task. Brain tissues were collected for evaluating the transcript levels of proinflammatory cytokines, whereas immunofluorescence staining and immunoblotting were conducted to determine the percentage of activated glia (microglia and astroglia) and damaged neurons and the expression of synaptic proteins and BDNF. Results: Cognitive impairment induced by systemic inflammation was significantly attenuated in the p47phox −/− mice compared to that in the WT mice. The p47phox −/− mice exhibited reduced microglial and astroglial activation and neuronal damage and attenuated the induction of multiple proinflammatory cytokines, including tumor necrosis factor-α, interleukin (IL)-1β, IL-6, and CCL2. Similar to that observed in the p47phox −/− mice, the administration of DPI significantly attenuated the cognitive impairment, reduced the glial activation and brain cytokine concentrations, and restored the expression of postsynaptic proteins (PSD-95) and BDNF in neurons and astrocytes, compared to those in the vehicle-treated controls within 10 days after LPS injection. Conclusions: This study clearly demonstrates that NOX2 contributes to glial activation with subsequent reduction in the expression of BDNF, synaptic dysfunction, and cognitive deficits after systemic inflammation in an LPS-injected mouse model. Our results provide evidence that NOX2 might be a promising pharmacological target that could be used to protect against synaptic dysregulation and cognitive impairment following systemic inflammation.

Original languageEnglish
Pages (from-to)242-252
Number of pages11
JournalBrain, Behavior, and Immunity
Publication statusPublished - 2020 Feb

All Science Journal Classification (ASJC) codes

  • Immunology
  • Endocrine and Autonomic Systems
  • Behavioral Neuroscience


Dive into the research topics of 'NADPH oxidase 2 as a potential therapeutic target for protection against cognitive deficits following systemic inflammation in mice'. Together they form a unique fingerprint.

Cite this